RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,896,420 | -49.2% | 2,365,805 | -24.2% | 0.54% | -50.8% |
| Q2 2023 | $39,193,744 | -23.7% | 3,120,521 | 0.0% | 1.09% | -41.9% |
| Q1 2023 | $51,394,981 | -11.2% | 3,120,521 | -19.5% | 1.88% | -23.1% |
| Q4 2022 | $57,907,754 | -40.3% | 3,876,021 | -10.7% | 2.44% | -39.1% |
| Q3 2022 | $97,075,000 | +32.2% | 4,339,521 | -1.0% | 4.01% | +13.1% |
| Q2 2022 | $73,445,000 | -45.8% | 4,384,805 | -3.2% | 3.55% | -34.6% |
| Q1 2022 | $135,601,000 | +41.0% | 4,530,605 | +44.7% | 5.42% | +55.4% |
| Q4 2021 | $96,141,000 | +48.8% | 3,130,605 | +52.8% | 3.49% | +38.4% |
| Q3 2021 | $64,609,000 | -39.9% | 2,049,113 | -30.3% | 2.52% | -37.4% |
| Q2 2021 | $107,509,000 | +8.2% | 2,938,202 | +2.3% | 4.03% | +8.2% |
| Q1 2021 | $99,325,000 | -22.2% | 2,873,147 | -6.5% | 3.72% | -25.9% |
| Q4 2020 | $127,720,000 | -11.2% | 3,073,147 | -9.0% | 5.02% | -35.9% |
| Q3 2020 | $143,885,000 | – | 3,378,380 | – | 7.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 4,068,574 | $68,149,000 | 5.76% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $467,408,000 | 3.71% |
| BVF INC/IL | 4,384,805 | $73,445,000 | 3.55% |
| Boxer Capital, LLC | 2,669,132 | $44,708,000 | 2.83% |
| Nextech Invest Ltd. | 475,485 | $7,964,000 | 2.69% |
| EcoR1 Capital, LLC | 3,723,541 | $62,369,000 | 2.15% |
| HARBOURVEST PARTNERS LLC | 296,402 | $4,965,000 | 1.63% |
| Integral Health Asset Management, LLC | 436,262 | $7,307,000 | 1.50% |
| Alphabet Inc. | 1,568,753 | $26,277,000 | 1.43% |
| Fernwood Investment Management, LLC | 185,063 | $3,100,000 | 1.34% |